Jiangxi Jinshuibao Pharmaceutical

Jiangxi Jinshuibao Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and commercialization of products derived from Cordyceps sinensis (caterpillar fungus). The company is best known for its flagship product, Jinshuibao tablets and capsules, which are widely used in Traditional Chinese Medicine (TCM) for treating chronic renal insufficiency, respiratory conditions, and immune deficiencies. As a subsidiary of China Resources Sanjiu (CR Sanjiu), the company leverages large-scale fermentation technology to produce high-quality fungal mycelium as a sustainable alternative to wild Cordyceps. Its portfolio focuses on nephrology, respiratory health, and general wellness, maintaining a significant market share in the Chinese TCM sector.